Literature DB >> 23828204

Therapeutic interventions and short-term outcomes for infants with severe bronchopulmonary dysplasia born at <32 weeks' gestation.

M A Padula1, T R Grover, B Brozanski, I Zaniletti, L D Nelin, J M Asselin, D J Durand, B L Short, E K Pallotto, F D Dykes, K M Reber, J R Evans, K Murthy.   

Abstract

OBJECTIVE: To characterize the treatments and short-term outcomes in infants with severe bronchopulmonary dysplasia (sBPD) referred to regional neonatal intensive care units. STUDY
DESIGN: Infants born <32 weeks' gestation with sBPD were identified using the Children's Hospital Neonatal Database. Descriptive outcomes are reported. RESULT: A total of 867 patients were eligible. On average, infants were born at 26 weeks' gestation and referred 43 days after birth. Infants frequently experienced lung injury (pneumonia: 24.1%; air leak: 9%) and received systemic corticosteroids (61%) and mechanical ventilation (median duration 37 days). Although 91% survived to discharge, the mean post-menstrual age was 47 weeks. Ongoing care such as supplemental oxygen (66%) and tracheostomy (5%) were frequently needed.
CONCLUSION: Referred infants with sBPD sustain multiple insults to lung function and development. Because affected infants have no proven, safe or efficacious therapy and endure an exceptional burden of care even after referral, urgent work is required to observe and improve their outcomes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23828204     DOI: 10.1038/jp.2013.75

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  10 in total

1.  Inter-center variation in death or tracheostomy placement in infants with severe bronchopulmonary dysplasia.

Authors:  K Murthy; N F M Porta; J M Lagatta; I Zaniletti; W E Truog; T R Grover; L D Nelin; R C Savani
Journal:  J Perinatol       Date:  2017-02-09       Impact factor: 2.521

2.  The Children's Hospitals Neonatal Database: an overview of patient complexity, outcomes and variation in care.

Authors:  K Murthy; F D Dykes; M A Padula; E K Pallotto; K M Reber; D J Durand; B L Short; J M Asselin; I Zaniletti; J R Evans
Journal:  J Perinatol       Date:  2014-03-06       Impact factor: 2.521

3.  Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia.

Authors:  Steven H Abman; Joseph M Collaco; Edward G Shepherd; Martin Keszler; Milenka Cuevas-Guaman; Stephen E Welty; William E Truog; Sharon A McGrath-Morrow; Paul E Moore; Lawrence M Rhein; Haresh Kirpalani; Huayan Zhang; Linda L Gratny; Susan K Lynch; Jennifer Curtiss; Barbara S Stonestreet; Robin L McKinney; Kevin C Dysart; Jason Gien; Christopher D Baker; Pamela K Donohue; Eric Austin; Candice Fike; Leif D Nelin
Journal:  J Pediatr       Date:  2016-11-28       Impact factor: 4.406

4.  Home Oxygen Use and 1-Year Readmission among Infants Born Preterm with Bronchopulmonary Dysplasia Discharged from Children's Hospital Neonatal Intensive Care Units.

Authors:  Joanne Lagatta; Karna Murthy; Isabella Zaniletti; Stephanie Bourque; William Engle; Rebecca Rose; Namasivayam Ambalavanan; David Brousseau
Journal:  J Pediatr       Date:  2020-02-21       Impact factor: 4.406

5.  The influence of small for gestational age status on outpatient bronchopulmonary dysplasia outcomes.

Authors:  J Johnson; T Ryan; A D Aherrera; S A McGrath-Morrow; J M Collaco
Journal:  J Perinatol       Date:  2014-08-07       Impact factor: 2.521

6.  Inhaled nitric oxide usage in preterm infants in the NICHD Neonatal Research Network: inter-site variation and propensity evaluation.

Authors:  W E Truog; L D Nelin; A Das; D E Kendrick; E F Bell; W A Carlo; R D Higgins; A R Laptook; P J Sanchez; S Shankaran; B J Stoll; K P Van Meurs; M C Walsh
Journal:  J Perinatol       Date:  2014-06-05       Impact factor: 2.521

7.  SOD2 activity is not impacted by hyperoxia in murine neonatal pulmonary artery smooth muscle cells and mice.

Authors:  Anita Gupta; Marta Perez; Keng Jin Lee; Joann M Taylor; Kathryn N Farrow
Journal:  Int J Mol Sci       Date:  2015-03-19       Impact factor: 5.923

8.  Differences in Comorbidities and Clinical Burden of Severe Bronchopulmonary Dysplasia Based on Disease Severity.

Authors:  Hye-Rim Kim; Young Hwa Jung; Beyong Il Kim; So Young Kim; Chang Won Choi
Journal:  Front Pediatr       Date:  2021-07-02       Impact factor: 3.418

9.  Outcomes of neonates with tracheostomy secondary to bronchopulmonary dysplasia.

Authors:  Kirtikumar Upadhyay; Dario Antonio Vallarino; Ajay J Talati
Journal:  BMC Pediatr       Date:  2020-09-01       Impact factor: 2.125

10.  Severe bronchopulmonary dysplasia: outcomes before and after the implementation of an inpatient multidisciplinary team.

Authors:  Robin L McKinney; Joseph J Schmidhoefer; Alyssa L Balasco; Jason T Machan; Priya Hirway; Martin Keszler
Journal:  J Perinatol       Date:  2020-10-23       Impact factor: 2.521

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.